VANI Vivani Medical, Inc.
Electromedical & Electrotherapeutic Apparatus · Nasdaq · SEC CIK 1266806 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY—
TTM net income YoY-3.9%
TTM EPS YoY26.7%
Revenue 3-yr CAGR—
Net income 3-yr CAGR—
Margins
Gross margin—
Operating margin—
Net margin—
FCF margin—
EBITDA margin—
Returns
ROE-372.2%
ROA-89.6%
ROIC (approx.)—
Asset turnover—
Leverage & solvency
Liabilities / assets62.6%
Debt / equity0.00x
Current ratio2.40x
Interest coverage—
Cash quality & payout
Operating cash flow / net income0.94x
Accruals ratio-5.6%
Payout ratio—
Capex / revenue—
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 |
|---|---|---|
| Income statement | ||
| Revenue | $0 | $0 |
| R&D expense | $18.13M | $15.74M |
| SG&A expense | $9.43M | $8.93M |
| Operating income | -$27.56M | -$24.68M |
| Pretax income | -$26.61M | -$23.49M |
| Income tax | — | $2,000 |
| Net income | -$26.61M | -$23.49M |
| EBITDA | -$27.13M | -$24.28M |
| EPS (basic) | -0.43 | -0.43 |
| EPS (diluted) | -0.43 | -0.43 |
| Weighted avg. shares (diluted) | 62.39M | 54.98M |
| Balance sheet | ||
| Cash & equivalents | $16.23M | $18.35M |
| Current assets | $17.90M | $20.44M |
| PP&E, net | $2.88M | $1.69M |
| Total assets | $39.39M | $41.56M |
| Current liabilities | $6.60M | $5.99M |
| Total liabilities | $23.66M | $23.95M |
| Shareholders' equity | $15.73M | $17.61M |
| Shares outstanding | 76.43M | 59.23M |
| Cash flow statement | ||
| Operating cash flow | -$24.32M | -$20.79M |
| Capital expenditure | $1.17M | $556,000 |
| Free cash flow | -$25.49M | -$21.34M |
| Investing cash flow | -$1.17M | -$556,000 |
| Financing cash flow | $23.27M | $19.05M |
| Depreciation & amortization | $424,000 | $400,000 |
| Stock-based compensation | $1.48M | $1.61M |
Free plan shows the latest 2 periods; Pro shows all 13 🔒
· This company does not report gross profit in XBRL.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.